About this episode
Takeaways
Menopausal women often prioritize weight gain concerns over other symptoms.
The study observed an association between hormone therapy and weight loss with GLP-1 medications.
Retrospective studies have limitations but can provide valuable insights.
Future research should focus on randomized controlled trials to confirm findings.
The relationship between estrogen and GLP-1 signaling needs further exploration.
Funding for research can be challenging, especially for early career investigators.
Collaboration between different specialties is crucial for comprehensive patient care.
The media often misrepresents research findings, leading to misconceptions.
Individualized treatment plans are essential for menopausal women.
There is a need for more awareness about the effects of menopause on health.
Research Links:
Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Docs Who Lift publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Docs Who Lift
Does Metabolically Healthy Obesity Even Exist?
Docs Who Lift
Is Your Obesity Genetic? Food Noise and Bardet-Biedl Syndrome Explained
Docs Who Lift
PCOS Renamed to PMOS? Here's Why and What Changes for You
Docs Who Lift
Are Peptides the New Snake Oil? What the Actual Science Says With Barbell Medici...
Docs Who Lift